Basit öğe kaydını göster

dc.contributor.authorYilmaz Oz, Basak
dc.contributor.authorKarabacak, Mert
dc.contributor.authorDelil, Sakir
dc.contributor.authorTAHMAZOĞLU, BURAK
dc.contributor.authorUZAN, MUSTAFA
dc.contributor.authorÖZLEN, FATMA
dc.contributor.authorİŞLER, CİHAN
dc.contributor.authorAkgun, Mehmet Yigit
dc.contributor.authorÖZKARA, ÇİĞDEM
dc.date.accessioned2022-07-04T13:52:34Z
dc.date.available2022-07-04T13:52:34Z
dc.date.issued2022
dc.identifier.citationÖZLEN F., İŞLER C., Akgun M. Y. , ÖZKARA Ç., Karabacak M., Delil S., Yilmaz Oz B., TAHMAZOĞLU B., UZAN M., "Factors Affecting Seizure Outcomes After Surgery for Cavernoma Related Epilepsy", TURKISH NEUROSURGERY, cilt.32, sa.3, ss.386-391, 2022
dc.identifier.issn1019-5149
dc.identifier.othervv_1032021
dc.identifier.otherav_5d79a127-fdb4-43da-8948-ada403789b0b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/182944
dc.identifier.urihttps://doi.org/10.5137/1019-5149.jtn.33806-21.2
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/5d79a127-fdb4-43da-8948-ada403789b0b/file
dc.description.abstractAIM: To present one of the largest retrospective cavernoma related epilepsy (CRE) studies which include divergent supratentorial locations operated and followed up at least 2 years. We also investigated the factors affecting the seizure outcome. MATERIAL and METHODS: This study includes a total of 56 patients with drug-responsive (n=40) and drug-resistant (n=16) CRE who underwent resective surgery. Age at seizure onset, age at surgery, gender, duration of epilepsy, seizure frequencies/type before and after treatment, EEG and brain MRI findings, prescribed AEDs, preoperative and post-operative neurological status, histopathological diagnosis, post-operative seizure outcomes and surgical information were documented. RESULTS: The average follow-up period was 69.6 months (range 24-216 months). The seizure outcome was assessed according to Engel???s classification at the last follow-up. Engel class I was achieved in 53 patients (95%); there was one patient at class II and two patients at class III. All patients in the drug-responsive group were at Engel class I after the surgery, while all patients at Engel classes II and III were in the drug-resistant patient group. This clearly shows that there were better outcomes in DRP group (p 0.01). Neither the locations of cavernomas nor the duration of epilepsy had any impact on seizure outcome (p 0.05). CONCLUSION: An earlier surgical intervention may prevent the patients from becoming drug-resistant such that their chances of being seizure free after surgery increase.
dc.language.isoeng
dc.subjectNeurology
dc.subjectNeurology (clinical)
dc.subjectSurgery
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectKLİNİK NEUROLOJİ
dc.subjectNöroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCerrahi Tıp Bilimleri
dc.titleFactors Affecting Seizure Outcomes After Surgery for Cavernoma Related Epilepsy
dc.typeMakale
dc.relation.journalTURKISH NEUROSURGERY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü
dc.identifier.volume32
dc.identifier.issue3
dc.identifier.startpage386
dc.identifier.endpage391
dc.contributor.firstauthorID3432096


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster